Journal of Affective Disorders, Journal Year: 2024, Volume and Issue: 365, P. 364 - 374
Published: Aug. 22, 2024
Language: Английский
Journal of Affective Disorders, Journal Year: 2024, Volume and Issue: 365, P. 364 - 374
Published: Aug. 22, 2024
Language: Английский
Balkan Sağlık Bilimleri Dergisi, Journal Year: 2025, Volume and Issue: 3(3), P. 164 - 186
Published: April 8, 2025
Bu derlemenin amacı, omega 3 yağ asitleri ile majör depresif bozukluk arasındaki ilişkiye genel bir bakış sunmaktır. Majör bozukluk, dünya çapında 280 milyon insanı etkileyen yaygın mental bozukluktur ve etiyolojisi tam olarak belli değildir. bozukluğu olan bireylerde, eritrosit membranlarında veya plazma fosfolipitlerinde düşük eikosapentaenoik asit + dokosaheksaenoik seviyeleri görülmektedir. nedenle, diyette asitleri, özellikle eksikliği bozukluğun patofizyolojisi arasında olası ilişki olduğu kabul edilmektedir. Son yıllarda omega-3 merkezi sinir sistemi üzerindeki potansiyel antidepresan etkileri nedeniyle depresyon tedavisinde dikkat çekmektedir. Bazı çalışmalar, takviyesi sonrasında semptomlarda anlamlı azalmalar bildirirken, diğer çalışmalar bu doğrulamamıştır. tutarsız bulgular, çalışma tasarımlarındaki farklılıklardan bireysel faktörlerden kaynaklanabilir. Ancak takviyeleri güvenli edilmekte standart tedavisine ek kullanılabilecekleri düşünülmektedir. alanda, daha geniş örneklem gruplarıyla tutarlı tasarımlarıyla yapılacak ileri araştırmalara ihtiyaç vardır.
Citations
0Ultrastructural Pathology, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 14
Published: April 11, 2025
Different researches suggests that unchecked maternal hyperglycemia during pregnancy may negatively impact the offspring's neurodevelopment. Omega 3 polyunsaturated fatty acids are vital antioxidant micronutrients for neurological health. Glutathione (GSH) is an essential non-enzymatic in mammalian cells. The study aimed to assess possible ameliorative effect of omega3 versus GSH against neuronal changes cingulate cortex new born rats diabetic mothers. Fifty female were divided randomly into 5 equal groups: Group I given saline, group II where induction diabetes by single intraperitoneal injection 150 mg/kg alloxan monohydrate, III oral omega at a dose 300 mg/kg, IV injections (200 mg/kg) and V both with same routes regimens as throughout whole pregnancy. newborn each was collected anaesthetized then brain specimens extracted processed light, immunohistochemical electron microscopic studies. showed marked degenerative all layers light microscopy. most degree improvement comparison IV. There strong caspase3 immunoreaction while weak reaction appeared III, V. We concluded combined administration mitigate adverse effects on newborn's cortex.
Language: Английский
Citations
0International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(9), P. 4271 - 4271
Published: April 30, 2025
The brain-derived neurotrophic factor (BDNF) has become one of the cornerstones neuropathology, influencing synaptic plasticity, cognitive resilience, and neuronal survival. Apart from its molecular biology, BDNF is a powerful target for transformative benefit in precision medicine, leading to innovative therapeutic approaches neurodegenerative psychiatric diseases like Alzheimer's disease (AD), Parkinson's (PD), major depressive disorder (MDD), post-traumatic stress (PTSD). Nevertheless, clinical applicability obstructed by hurdles delivery, patient-specific diversity, pleiotropic signaling. Here, we summarize findings research, including regulatory pathways diagnostic/prognostic biomarkers integrative approaches. We describe delivery systems, such as lipid nanoparticle-based mRNA therapies CRISPR-dCas9-based epigenetic editing that bypass obstacles BBB (blood-brain barrier) enzymatic degradation. recent implementation multiplex panels combining biodynamic indicators with tau amyloid-β signaling markers showcases novel levels specificity both early detection potential monitoring. Humanized preclinical models iPSC-derived neurons organoids point key role neurodeveloping processes, paralleling advances bridging observation environments. Moreover, tools delivering TrkB activators or AI-based dynamic care platforms enable tailored scalable treatments. This review also aims extend framework used understanding BDNF's relevance traditional situating more work detailing actions ischemic tissues gut-brain axis context systemic health. Finally, outline roadmap incorporation BDNF-centered into worldwide healthcare, highlighting ethical issues, equity, interdisciplinary decomposition. heralds new era neuroscience revolutionizing brain health paving way advancement medicine.
Language: Английский
Citations
0Cells, Journal Year: 2024, Volume and Issue: 13(15), P. 1259 - 1259
Published: July 26, 2024
This review discusses the potential of targeting kynurenine pathway (KP) in treatment inflammatory diseases. The KP, responsible for catabolism amino acid tryptophan (TRP), produces metabolites that regulate various physiological processes, including inflammation, cell cycle, and neurotransmission. These metabolites, although necessary to maintain immune balance, may accumulate excessively during leading systemic disorders. Key KP enzymes such as indoleamine 2,3-dioxygenase 1 (IDO1), 2 (IDO2), (TDO), 3-monooxygenase (KMO) have been considered promising therapeutic targets. It was highlighted both inhibition activation these be beneficial, depending on specific disorder. Several conditions, autoimmune diseases, which modulation activity holds promise, described detail. Preclinical studies suggest this an effective strategy diseases options are currently limited. Taken together, highlights importance further research clinical application enzyme development new strategies
Language: Английский
Citations
3Journal of Affective Disorders, Journal Year: 2024, Volume and Issue: 365, P. 364 - 374
Published: Aug. 22, 2024
Language: Английский
Citations
3